2682850-41-3
Chemical Structure
RIP1/RIP3/MLKL activator 1
- CAS No.: 2682850-41-3
- Formula:C43H56N4O3
- Molecular Weight:676.93
IUPAC Name: (2R,4aS,6aS,12bR,14aS)-N-((1-(4-(tert-butyl)benzyl)-1H-1,2,3-triazol-4-yl)methyl)-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydropicene-2-carboxamide
InChIKey: QLFCJGYFBTYJGC-RSWNTZNOSA-N
SMILES: CC1=C(C(C=C2C1=CC=C3[C@]4(CC[C@]5(CC[C@@](C(NCC6=CN(N=N6)CC7=CC=C(C=C7)C(C)(C)C)=O)(CC5[C@@]4(CC[C@@]23C)C)C)C)C)=O)O
Biological Activity: RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RIP1/RIP3/MLKL activator 1 | 97.0% | RIP1/RIP3/MLKL activator 1 (Compound 6i) is a potent anti-glioma agent. RIP1/RIP3/MLKL activator 1 induces necroptosis through RIP1/RIP3/MLKL pathway. RIP1/RIP3/MLKL activator 1 exerts acceptable BBB permeability. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
